158 related articles for article (PubMed ID: 29728083)
1. Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry.
Dougan MM; Li Y; Chu LW; Haile RW; Whittemore AS; Han SS; Moore SC; Sampson JN; Andrulis IL; John EM; Hsing AW
BMC Cancer; 2018 May; 18(1):532. PubMed ID: 29728083
[TBL] [Abstract][Full Text] [Related]
2. A plasma metabolomic signature discloses human breast cancer.
Jové M; Collado R; Quiles JL; Ramírez-Tortosa MC; Sol J; Ruiz-Sanjuan M; Fernandez M; de la Torre Cabrera C; Ramírez-Tortosa C; Granados-Principal S; Sánchez-Rovira P; Pamplona R
Oncotarget; 2017 Mar; 8(12):19522-19533. PubMed ID: 28076849
[TBL] [Abstract][Full Text] [Related]
3. Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.
Wang X; Zhao X; Chou J; Yu J; Yang T; Liu L; Zhang F
Cancer Biomark; 2018; 23(2):255-268. PubMed ID: 30103303
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies.
Townsend MK; Clish CB; Kraft P; Wu C; Souza AL; Deik AA; Tworoger SS; Wolpin BM
Clin Chem; 2013 Nov; 59(11):1657-67. PubMed ID: 23897902
[TBL] [Abstract][Full Text] [Related]
5. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer.
Fan Y; Zhou X; Xia TS; Chen Z; Li J; Liu Q; Alolga RN; Chen Y; Lai MD; Li P; Zhu W; Qi LW
Oncotarget; 2016 Mar; 7(9):9925-38. PubMed ID: 26848530
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometry.
Trabert B; Falk RT; Stanczyk FZ; McGlynn KA; Brinton LA; Xu X
Horm Mol Biol Clin Investig; 2015 Sep; 23(3):79-84. PubMed ID: 26353176
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations.
Guertin KA; Moore SC; Sampson JN; Huang WY; Xiao Q; Stolzenberg-Solomon RZ; Sinha R; Cross AJ
Am J Clin Nutr; 2014 Jul; 100(1):208-17. PubMed ID: 24740205
[TBL] [Abstract][Full Text] [Related]
8. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
9. Serum Metabolomic Profiles for Breast Cancer Diagnosis, Grading and Staging by Gas Chromatography-Mass Spectrometry.
Hadi NI; Jamal Q; Iqbal A; Shaikh F; Somroo S; Musharraf SG
Sci Rep; 2017 May; 7(1):1715. PubMed ID: 28496143
[TBL] [Abstract][Full Text] [Related]
10. Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.
Cala MP; Aldana J; Medina J; Sánchez J; Guio J; Wist J; Meesters RJW
PLoS One; 2018; 13(2):e0190958. PubMed ID: 29438405
[TBL] [Abstract][Full Text] [Related]
11. NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer.
Lécuyer L; Victor Bala A; Deschasaux M; Bouchemal N; Nawfal Triba M; Vasson MP; Rossary A; Demidem A; Galan P; Hercberg S; Partula V; Le Moyec L; Srour B; Fiolet T; Latino-Martel P; Kesse-Guyot E; Savarin P; Touvier M
Int J Epidemiol; 2018 Apr; 47(2):484-494. PubMed ID: 29365091
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk in relation to plasma metabolites among Hispanic and African American women.
Zhao H; Shen J; Moore SC; Ye Y; Wu X; Esteva FJ; Tripathy D; Chow WH
Breast Cancer Res Treat; 2019 Aug; 176(3):687-696. PubMed ID: 30771047
[TBL] [Abstract][Full Text] [Related]
13. Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort.
Lécuyer L; Dalle C; Lyan B; Demidem A; Rossary A; Vasson MP; Petera M; Lagree M; Ferreira T; Centeno D; Galan P; Hercberg S; Deschasaux M; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Durand S; Pujos-Guillot E; Touvier M
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1300-1307. PubMed ID: 31164347
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.
Lopes AS; Cruz EC; Sussulini A; Klassen A
Adv Exp Med Biol; 2017; 965():77-98. PubMed ID: 28132177
[TBL] [Abstract][Full Text] [Related]
15. Comparative study on microsampling techniques in metabolic fingerprinting studies applying gas chromatography-MS analysis.
Cala MP; Meesters RJ
Bioanalysis; 2017 Sep; 9(17):1329-1340. PubMed ID: 28901168
[TBL] [Abstract][Full Text] [Related]
16. Prospective analysis of circulating metabolites and breast cancer in EPIC.
His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
[TBL] [Abstract][Full Text] [Related]
17. Differences in metabolite profiles caused by pre-analytical blood processing procedures.
Nishiumi S; Suzuki M; Kobayashi T; Yoshida M
J Biosci Bioeng; 2018 May; 125(5):613-618. PubMed ID: 29258730
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
Woo HM; Kim KM; Choi MH; Jung BH; Lee J; Kong G; Nam SJ; Kim S; Bai SW; Chung BC
Clin Chim Acta; 2009 Feb; 400(1-2):63-9. PubMed ID: 19010317
[TBL] [Abstract][Full Text] [Related]
19. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
